Highline Capital Management, L.P. / SRPT
Highline Capital Management, L.P.’s Sarepta Therapeutics Inc Position
Does Highline Capital Management, L.P. own Sarepta Therapeutics Inc (SRPT)? Not currently — the last reported position was 436.0K shares worth $52M in Q1 2019; the fund’s latest 13F (Q4 2022) no longer reports it.
Position Value
$52M
Q1 2019
Shares
436.0K
% of Portfolio
+3.27%
Quarters Held
1
position exited
Position History SRPT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2019 | 436.0K | $52M | +3.27% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highline Capital Management, L.P.’s full portfolio or all institutional holders of SRPT.